Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
This syndrome is characterized by primary hypergonadotropic hypogonadism and partial alopecia.
Features include: Alopecia, Hypergonadotropic hypogonadism, and Streak ovary.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 1 | Alopecia |
Hormones | 1 | Hypergonadotropic hypogonadism |
Biomarker and diagnostic research for primary hypergonadotropic hypogonadism-partial alopecia syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for primary hypergonadotropic hypogonadism-partial alopecia syndrome.
102 publications have been identified in PubMed for primary hypergonadotropic hypogonadism-partial alopecia syndrome. Kisho has analyzed 47 by research type. Research spans Other (45%), Review / Meta-Analysis (30%), and Basic Science / Preclinical (9%).
Research Type | Count | % of Total |
|---|---|---|
Other research | 21 | 45% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 3:08 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
14 |
30% |
Laboratory research | 4 | 9% |
Testing and diagnosis research | 3 | 6% |
Patient case studies | 2 | 4% |
Disease patterns and progression | 2 | 4% |
New treatment approaches | 1 | 2% |
Al Amin ASM (2026). [PMID: 32965966](https://pubmed.ncbi.nlm.nih.gov/32965966/). *Unknown Journal*. [Other]
Davalan W (2026). [PMID: 41173227](https://pubmed.ncbi.nlm.nih.gov/41173227/). *Exp Neurol*. [Review / Meta-Analysis]
Sumaily IA (2026). [PMID: 37449389](https://pubmed.ncbi.nlm.nih.gov/37449389/). *Ear Nose Throat J*. [Review / Meta-Analysis]
Balasundaram P (2026). [PMID: 34033359](https://pubmed.ncbi.nlm.nih.gov/34033359/). *Unknown Journal*. [Other]
Ray A (2026). [PMID: 34283446](https://pubmed.ncbi.nlm.nih.gov/34283446/). *Unknown Journal*. [Gene Therapy / Novel Therapeutics]
Gay JT (2026). [PMID: 30020643](https://pubmed.ncbi.nlm.nih.gov/30020643/). *Unknown Journal*. [Other]
Muzio MR (2026). [PMID: 31613525](https://pubmed.ncbi.nlm.nih.gov/31613525/). *Unknown Journal*. [Other]
Williams GM (2026). [PMID: 30855930](https://pubmed.ncbi.nlm.nih.gov/30855930/). *Unknown Journal*. [Other]
Nguyen J (2026). [PMID: 40198044](https://pubmed.ncbi.nlm.nih.gov/40198044/). *Unknown Journal*. [Other]
Bustamante JG (2026). [PMID: 29261990](https://pubmed.ncbi.nlm.nih.gov/29261990/). *Unknown Journal*. [Other]